Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy

Background A relatively high mortality of severe coronavirus disease 2019 (COVID‐19) is worrying, and the application of heparin in COVID‐19 has been recommended by some expert consensus because of the risk of disseminated intravascular coagulation and venous thromboembolism. However, its efficacy r...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of thrombosis and haemostasis Ročník 18; číslo 5; s. 1094 - 1099
Hlavní autori:	Tang, Ning, Bai, Huan, Chen, Xing, Gong, Jiale, Li, Dengju, Sun, Ziyong
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	England Elsevier Limited 01.05.2020 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc
Predmet:	Age Factors Aged Anticoagulants Anticoagulants - administration & dosage Anticoagulants - therapeutic use Betacoronavirus Biomarkers - blood Blood Coagulation Tests coagulopathy Coronaviridae coronavirus disease 2019 Coronavirus Infections - complications Coronavirus Infections - drug therapy Coronavirus Infections - mortality Coronaviruses COVID-19 Disseminated intravascular coagulation Disseminated Intravascular Coagulation - drug therapy Disseminated Intravascular Coagulation - etiology D‐dimer Female Fibrin Fibrinogen Degradation Products Health risk assessment Heparin Heparin, Low-Molecular-Weight - administration & dosage Heparin, Low-Molecular-Weight - therapeutic use Humans low molecular weight heparin Male Middle Aged Molecular weight Mortality Multivariate analysis Original Pandemics Patients Platelet Count Pneumonia, Viral - complications Pneumonia, Viral - drug therapy Pneumonia, Viral - mortality Prognosis Prothrombin Prothrombin Time Retrospective Studies SARS-CoV-2 Sepsis Survival Rate Thromboembolism D-dimer low molecular weight heparin coagulopathy coronavirus disease 2019 sepsis
ISSN:	1538-7933, 1538-7836, 1538-7836
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!